Figure 6. Retrograde labeling of the corticopontine cells revealed layer 5-restricted elaboration of the dendritic processes.
Image credit: Watakabe, et. al. 2012 under CC BY license

Funding Opportunities

To submit any new grant opportunities for this list, please email List the sponsor name, amount, due date, and contact information.



Current Funding Opportunities:

NEW! Accelerating Therapies: Public-Private Partnership Program (ATP3)
Sponsor: California Institute for Regenerative Medicine (CIRM)
Description: CIRM’s Infrastructure Programs are designed to address the challenges that currently slow the progress of translating promising stem cell technologies into high quality clinical trials and ultimately towards commercialization. The CIRM ATP3 Public-Private Partnership program, is designed to create an enterprise that will aggregate CIRM's most promising stem cell technologies and advance them towards commercialization. CIRM will be the public partner and is looking for a company to take on the private partner role.
Deadline: Application due by October 31, 2016.

The ALS Assistive Technology Challenge
Sponsor: ALS Association (ALSA) and Prize4Life
Description: The ALS Assistive Technology Challenge, a joint initiative by The ALS Association and Prize4Life,  is offering a $400,000 prize for the development of flexible, accessible technology to help people with ALS communicate with ease. The challenge is open to academics, industry, young start-ups and anyone that believes they can make a difference for people living with ALS.
Deadline: Letter of intent due by July 29, 2016.

ALS Research Grants
Sponsor: The Judith and Jean Pape Adams Foundation
Description: The Foundation is interested in supporting research that is aimed at discovering the causes of and finding a cure for ALS. The Foundation funds research that is innovative and aggressive. We encourage partnerships and collaborative efforts in proposing initiatives to fill gaps not currently being investigated and that involve novel approaches.  The research must be of high scientific merit.
Deadline: Application due by August 12, 2016.

Accelerating Drug Discovery for Frontotemporal Degeneration
Sponsor: Alzheimer’s Drug Discovery Foundation and The Association for Frontotemporal Degeneration (AFTD)
Description: The objective of this grant is to accelerate drug discovery programs and biomarker development for frontotemporal degeneration.
Deadline: Application due by August 12, 2016.

MND Australia Grants-in-aid
Sponsor: MND Australia
Description: Seed-funding for research that is innovative and has a clear relationship to the causes, treatments and cures of MND or the support of people living with MND. Applicants must be researchers working in Australia on an international collaboration.  
Deadline: Application due by August 26, 2016.

MND Australia Postdoctoral Research Fellowship
Sponsor: MND Australia
Description: These three-year Fellowships aim to encourage young researchers to focus their interest on MND. The Fellowship is directed towards postdoctoral scientists with a track record in areas of neuroscience related to MND and no more than three years postdoctoral research experience. Applicant must be an Australian citizen or have permanent residential status.
Deadline: Application due by August 26, 2016.

Target ALS Foundation Industry-Led Consortia
Sponsor: Target ALS Foundation
Description: This call aims to encourage ALS research ideation and active involvement from the pharma/biotech industry. The chosen mechanism is to fund “Industry-Led Consortia (ILCs)” that bring together investigators from pharma/biotech and academia to work on a collaborative project (groups of 2-4 laboratories working around a common research theme or target). TOPICS OF INTEREST: Target ALS is particularly interested in receiving projects that focus on identification, validation and development of new targets for ALS therapeutics, or for novel biomarkers and other tools to facilitate human proof-of-biology studies.
Deadline: Letter of intent due by August 31, 2016.

Target ALS Foundation Young Investigator-Led Collaborative Projects
Sponsor: Target ALS Foundation
Description: Target ALS Foundation is an independent non-profit 501(c)(3) foundation working to accelerate ALS drug development and break down barriers to ALS research. Another major focus has been to identify and support the next generation of ALS research leaders, in part through our ALS Springboard Fellowship program for newly independent investigators. We now wish to provide further leadership opportunities to this group – in both academic and pharma/biotech settings - by funding a new series of grants called Young Investigator-Led Collaborative Projects (YICPs), led by them and involving scientists from across the field.
Deadline: Letter of intent due by August 31, 2016.

Frick Foundation for ALS Research Grants
Sponsor: Frick Foundation for ALS Research
Description: The Bruno and Ilse Frick Foundation for Research on ALS is calling for grant applications. The aim of the Foundation is to encourage basic biomedical research related to understanding the cause of ALS.
Deadline: Application due by September 30, 2016.

Motor Neuron disease Association (MNDA) Biomedical Research Project Grants
Sponsor: Motor Neuron disease Association (MNDA)
Description: MNDA's Biomedical Research Programme is delivering significant and measurable advances in understanding and treating MND/ALS. Only research of the highest scientific excellence and greatest relevance to MND is funded.
Deadline: Summary Application due by October 28, 2016.

DISC 1: The Inception Awards
Sponsor: California Institute for Regenerative Medicine (CIRM)
Description: The CIRM Inception Awards Program provides seed funding to support the exploration of transformational ideas that hold the potential to greatly impact the field of human stem cell research, but that require the generation of additional data to be competitive for larger funding opportunities through CIRM or other sources.
Deadline: Application due by November 2016.

ALS Canada Clinical Management Grant
Sponsor: ALS Canada
Description: Grant to support formal assessment of ALS clinical care options and decisions made by clinians, patients and families. Examples include, but are not limited to, management of secretions and cramps, psychological interventions to address mental health issues, nutritional interventions, respiratory care, engineering applications to reduce physical limitations, and programs to address the needs of caregivers. EligibilityThe principal applicant must be a clinician with an MD or a non-physician professional with experience treating or working with people living with ALS. The PI must hold an academic position at a qualifying Canadian institution.
Deadline: Application due by November 4, 2016.

Basic Biopsychosocial Mechanisms and Processes in the Management of Chronic Conditions (R21)
Sponsor: NIH Basic Behavioral and Social Science Opportunity Network (OppNet)
Description: This funding opportunity seeks to stimulate basic inquiry into the mechanisms that influence people within their larger social contexts to manage one or multiple conditions over the lifecourse. Long-term goals are to increase knowledge of the individual and group processes that inform thought and behaviors that reinforce health and optimal wellbeing to enhance overall human health, reduce illness and disability, and lengthen life.
Deadline: Letter of intent due by November 6, 2016.

MNDRIA PhD Scholarship Top-up Grant
Sponsor: The Motor Neurone Disease Research Institute of Australia (MNDRIA)
Description: This grant is an incentive for an outstanding student with a top-up for the PhD stipend provided by their University.  The 3-year PhD top-up grant will be offered for a student who has been awarded a University PhD scholarship for biomedical or public health research in MND. Applicants must be PhD students who have commenced their PhD in 2015 or students who have applied to a University for a PhD scholarship to commence in 2016.
Deadline: Application due by January 27, 2017.

CLIN 2: Partnering Opportunity for Clinical Trial Stage Projects
Sponsor: California Institute of Regenerative Medicine (CIRM)
Description: The objective of this program announcement is to create a highly competitive partnering opportunity for promising stem cell-based projects to accelerate the completion of a clinical trial for a stem cell treatment that addresses an unmet medical need.
Deadline: Last business day of each month.

CLIN 3: Partnering Opportunity for Supplemental Accelerating Activities
Sponsor: California Institute of Regenerative Medicine (CIRM)
Description: The objective of this program announcement is to support new activities on active CIRM-funded development projects that will significantly accelerate development of the proposed treatment or increase the likelihood of success.
Deadline: Last business day of each month.

Clin1: Partnering Opportunity for Late Stage Preclinical Projects
Sponsor: California Institute of Regenerative Medicine (CIRM)
Description: The objective of this program announcement is to create a highly competitive partnering opportunity for promising stem cell-based projects to accelerate the completion of preclinical activities necessary to attain an active IND or IDE with the FDA and to initiate start-up activities of the proposed clinical trial. CIRM expects projects under this program to advance rapidly into the clinic and to be accomplished within two years unless adequately justified.
Deadline: Last business day of each month.

Healthcare Research Grants
Sponsor: Motor Neurone Disease Association (MNDA)
Description: MNDA invests in research that fills knowledge gaps in clinical management of MND, adding to the evidence base and driving improvements in quality of care for people affected by MND.  
Deadline: Now accepting applications.

NIH TRND Program and NIH BrIDGs Program
Sponsor: NIH National Center for Advancing Translational Sciences (NCATS)
Description: NCATS is now accepting proposals on a rolling basis to collaborate with Bridging Interventional Development Gaps (BrIDGs) and Therapeutics for Rare and Neglected Diseases (TRND) program scientists. Click here to apply.
Deadline: Now accepting rolling applications.

Share this: